Corrigendum to "Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection" [J. Clin. Virol. 37 (2006) 282-286] (DOI:10.1016/j.jcv.2006.08.012);Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection

Journal of Clinical Virology

Volumn 37, Issue 4, 2006, Pages 282-286

  He, YingLi ^a   Zhao, YingRen ^a   Zhang, ShuLin ^a   Chen, Wei ^a   Lin, ShuMei ^a   Yang, Qian ^a   Liu, JinFeng ^a   Yang, Yuan ^a   Jin, Yan ^a   Liu, Ming ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Class II transactivator; CpG island; Hepatitis B virus; Major histocompability complex; Methylation

Indexed keywords

CLASS II TRANSACTIVATOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ARTICLE; BIOINFORMATICS; BLOOD DONOR; CHRONIC HEPATITIS; CONTROLLED STUDY; GENE SEQUENCE; GENETIC POLYMORPHISM; HEPATITIS B; HEPATITIS B VIRUS; HOST SUSCEPTIBILITY; HUMAN; INFECTION SENSITIVITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; METHYLATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 33750494311     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.12.008     Document Type: Erratum

References (25)

1. Al Faress S., Cartet G., Ferraris O., Norder H., Valette M., and Lina B. Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002. J Clin Virol 33 (2005) 230-236
2. Bennett S., Lienhardt C., Bah-Sow O., Gustafson P., Manneh K., Del Prete G., et al. Investigation of environmental and host-related risk factors for tuberculosis in Africa. II. Investigation of host genetic factors. Am J Epidemiol 155 (2002) 1074-1079
3. Chen Y., Wei H., Gao B., Hu Z., Zheng S., and Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepatol 12 (2005) 38-45
4. Godkin A., Davenport M., and Hill A.V. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41 (2005) 1383-1390
5. Goodwin B.L., Xi H., Tejiram R., Eason D.D., Ghosh N., Wright K.L., et al. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Cell Growth Differ 12 (2001) 327-335
6. Grunau C., Clark S.J., and Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucl Acids Res 29 (2001) E65-E165
7. Harton J.A., and Ting J.P. Class II transactivator: mastering the art of major histocompatibility complex expression. Mol Cell Biol 20 (2000) 6185-6194
8. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 (1996) 9821-9826
9. Hou J., Liu Z., and Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci 2 (2005) 50-57
10. Hui C.K., and Lau G.K. Immune system and hepatitis B virus infection. J Clin Virol 34 Suppl 1 (2005) S44-S48
11. Kawasaki H., and Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 431 (2004) 211-217
12. Lok A.S. The maze of treatments for hepatitis B. N Engl J Med 352 (2005) 2743-2746
13. Lok A.S., and McMahon B.J. AASLD practice guidelines, chronic hepatitis B: update of therapeutic guidelines. Rom J Gastroenterol 13 (2004) 150-154
14. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16 (1988) 1215
15. Morris A.C., Spangler W.E., and Boss J.M. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control. J Immunol 164 (2000) 4143-4149
16. Morris A.C., Beresford G.W., Mooney M.R., and Boss J.M. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol Cell Biol 22 (2002) 4781-4791
17. Muhlethaler-Mottet A., Otten L.A., Steimle V., and Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 16 (1997) 2851-2860
18. Quan V., Towey M., Sacks S., and Kelly A.P. Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA. Immunogenetics 49 (1999) 957-963
19. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
20. Sasaki M., Anast J., Bassett W., Kawakami T., Sakuragi N., and Dahiya R. Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation. Biochem Biophys Res Commun 309 (2003) 305-309
21. Steimle V., Otten L.A., Zufferey M., and Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75 (1993) 135-146
22. Thio C.L., Thomas D.L., Karacki P., Gao X., Marti D., Kaslow R.A., et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 77 (2003) 12083-12087
23. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5 (2005) 223-231
24. van den Elsen P.J., van der Stoep N., Vietor H.E., Wilson L., van Zutphen M., and Gobin S.J. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA. Hum Immunol 61 (2000) 850-862
25. Villeneuve J.P. The natural history of chronic hepatitis B virus infection. J Clin Virol 34 Suppl. 1 (2005) S139-S142